STAT+: How $500 explains Republican health policy, and the GLP-1 Rx wave
Reported by STAT News · all stories from statnews.com
Editorial digest
This story explores how a specific $500 figure helps to explain current Republican healthcare policy approaches. It also covers the growing trend in prescriptions for GLP-1 class medications.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom11/5/2026
STAT+: What the midterms could mean for the future of health AI
Upcoming midterm election outcomes could reshape regulatory policies and federal oversight for medical artificial intelligence technologies.
- Trusted health newsroom11/3/2026
STAT+: FDA, CMS look to collaborate with states on health AI
Federal regulators at the FDA and CMS plan to partner with state authorities regarding medical artificial intelligence.
- Trusted health newsroom9/30/2026
STAT+: What health tech leaders are talking about in Washington policy circles
Leaders in health technology are discussing policy matters in Washington.
- Trusted health newsroom10/28/2026
STAT+: As Epic’s dominance grows, its iron grip is choking innovation in health technology
Epic Systems' expanding market influence is reportedly stifling technological innovation across the healthcare sector.
- Trusted health newsroom10/26/2026
STAT+: HHS relaxes security, transparency rules for health record software used by hospitals
Federal health officials have eased transparency and data protection mandates for hospital electronic record platforms.
- Trusted health newsroom10/22/2026
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
Virtual clinics are providing off-label GLP-1 therapies for substance use disorders before receiving formal regulatory authorization.
